IL-36 Receptor Is Required for Resolution of Intestinal Damage

被引：2
|
作者：
Harusato, Akihito [1 ]
Medina-Contreras, Oscar [2 ]
Nishio, Hikaru [3 ]
Chassaing, Benoit [1 ]
Gewirtz, Andrew [1 ]
Parkos, Charles [4 ]
Townek, Jennifer [5 ]
Nusrat, Asma [4 ]
Denning, Timothy [2 ]
机构：
[1] Georgia State Univ, Atlanta, GA 30303 USA
[2] Georgia State Univ, Dept Biol, Ctr Inflammat Immun & Infect, Atlanta, GA USA
[3] Emory Univ, Atlanta, GA 30322 USA
[4] Univ Michigan, Ann Arbor, MI 48109 USA
[5] Amgen Inc, Seattle, WA USA
来源：
INFLAMMATORY BOWEL DISEASES | 2016年 / 22卷
关键词：
D O I：
10.1097/01.MIB.0000480273.37247.26
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P-146
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [1] Cutting Edge: IL-36 Receptor Promotes Resolution of Intestinal Damage
    Medina-Contreras, Oscar
    Harusato, Akihito
    Nishio, Hikaru
    Flannigan, Kyle L.
    Ngo, Vu
    Leoni, Giovanna
    Neumann, Philipp-Alexander
    Geem, Duke
    Lili, Loukia N.
    Ramadas, Ravisankar A.
    Chassaing, Benoit
    Gewirtz, Andrew T.
    Kohlmeier, Jacob E.
    Parkos, Charles A.
    Towne, Jennifer E.
    Nusrat, Asma
    Denning, Timothy L.
    [J]. JOURNAL OF IMMUNOLOGY, 2016, 196 (01): : 34 - 38
  • [2] Profile of IL-36 cytokines (IL-36α, IL-36β, IL-36γ and IL-36Ra) in patients with primary immune thrombocytopenia
    Wang, Shuang
    Liu, Yang
    Nie, Mu
    Li, Qianpeng
    Liu, Yu
    [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 82
  • [3] The role of IL-36 subfamily in intestinal disease
    Xu, Peng
    Guan, Haidi
    Xiao, Weidong
    Sun, Lihua
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2022, 50 (01) : 223 - 230
  • [4] Interleukin-36 (IL-36) Ligands Require Processing for Full Agonist (IL-36α, IL-36β, and IL-36γ) or Antagonist (IL-36Ra) Activity
    Towne, Jennifer E.
    Renshaw, Blair R.
    Douangpanya, Jason
    Lipsky, Brian P.
    Shen, Min
    Gabel, Christopher A.
    Sims, John E.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (49) : 42594 - 42602
  • [5] IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist
    van de Veerdonk, Frank L.
    Stoeckman, Angela K.
    Wu, Gouping
    Boeckermann, Aaron N.
    Azam, Tania
    Netea, Mihai G.
    Joosten, Leo A. B.
    van der Meer, Jos W. M.
    Hao, Ruyi
    Kalabokis, Vassili
    Dinarello, Charles A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (08) : 3001 - 3005
  • [6] Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barre syndrome
    Zhao, Zhikang
    Zhang, Rui
    Gao, Xinxin
    Li, Hui
    Liu, Hongbo
    [J]. MEDICINE, 2020, 99 (52)
  • [7] Rationale for IL-36 receptor antibodies in ulcerative colitis
    Neufert, Clemens
    Neurath, Markus F.
    Atreya, Raja
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (04) : 339 - 342
  • [8] IL-36 in psoriasis
    Towne, J. E.
    Sims, J. E.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2012, 12 (04) : 486 - 490
  • [9] IL-36 receptor is expressed by human blood and intestinal T lymphocytes and is dose-dependently activated via IL-36β and induces CD4+lymphocyte proliferation
    Penha, Rafael
    Higgins, John
    Mutamba, Shilla
    Barrow, Paul
    Mahida, Yashwant
    Foster, Neil
    [J]. CYTOKINE, 2016, 85 : 18 - 25
  • [10] IL-36 RECEPTOR ANTAGONIST WITH SPECIAL EMPHASIS ON IL-38
    Shaik, Y.
    Sabatino, G.
    Maccauro, G.
    Varvara, G.
    Murmura, G.
    Saggini, A.
    Rosati, M.
    Conti, F.
    Cianchetti, E.
    Caraffa, A.
    Antinolfi, P.
    Pandolfi, F.
    Potalivo, G.
    Galzio, R.
    Conti, P.
    Theoharides, T. C.
    [J]. INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2013, 26 (01): : 27 - 36
12345